Subscribe to Newsletter

Advanced Medicine

Manufacture Advanced Medicine

Open or Closed?

| Krishnendu Khan | 5 min read

How to find the right balance in cell therapy manufacturing.

Manufacture Advanced Medicine

Interviewing Paul Donohoue: A Guiding RNA-DNA Light for CRISPR

| Stephanie Vine | 12 min read

The story of how Caribou Biosciences developed a hybrid RNA-DNA guide to increase Cas9 specificity.

Business & Regulation Profession

Interviews To Inspire

| Jamie Irvine

Our roundup of some of our thoughtful and inspiring video interviews and roundtables from the past year.

Business & Regulation Profession

Canadian Careers in Cell and Gene

| Stephanie Vine | 4 min read

Exploring the gaps and opportunities in Canada’s cell and gene workforce.

Manufacture Advanced Medicine

Notes, Quotes, and Anecdotes: Words of Wisdom from 2023

| Rob Coker | 5 min read

A selection of some of the most poignant words spoken by interviewees this year

Manufacture Advanced Medicine

Got You Covered

| Stephanie Vine | 3 min read

From flu vaccines, to gene editing, to antibody drug conjugates, and women’s careers; we look back on our 2023 magazine covers.

Manufacture Advanced Medicine

Format and Function: Optimizing Gene Therapy Manufacturing Workflow

| Elpidia Gamez | 4 min read

Gene therapy has the potential to transform lives, but promising treatments for a wide range of diseases require optimal cell culture media solutions

Business & Regulation Quality & Compliance

The FDA Investigates T-Cell Malignancies in CAR-T Therapy

| Jamie Irvine | 4 min read

The details and reactions behind a recent FDA investigation into the cancer-risk of CAR-T therapies

Manufacture Advanced Medicine

Droplet Digital PCR Technology for Accelerated Gene Therapy Testing

| Sponsored by Bio-Rad Laboratories | 5 min read

Why drug developers are turning to this technique for rapid detection of replication-competent viruses.

Business & Regulation Standards & Regulation

The Ethical Issues of Advanced Medicine

| Sumukhi Sreevatsan | 3 min read

How do we encourage the development of new cell and gene therapies without compromising our ethics?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register